![Timothy E. Morey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Timothy E. Morey
Corporate Officer/Principal at University of Florida
Timothy E. Morey active positions
Companies | Position | Start | End |
---|---|---|---|
University of Florida | Corporate Officer/Principal | 25/11/2009 | - |
Career history of Timothy E. Morey
Former positions of Timothy E. Morey
Companies | Position | Start | End |
---|---|---|---|
NanoMedex Pharmaceuticals, Inc.
![]() NanoMedex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NanoMedex Pharmaceuticals, Inc. develops formulation strategy to allow drugs that are only soluble in oil to be soluble in water. It offers offers Microfol, a micro emulsion formulation containing the generic active pharmaceutical ingredient propofol and two IIG listed excipients-sodium caprylate and poloxamer, which replaces the macro emulsion components of the reference listed drug and its generic equivalents. The company’s formulation is applied to drug classes, including chemotherapeutics, anesthetics, anti-infective, anti-inflammatories and arrythmics, immunosuppressants, and vitamins. NanoMedex Pharmaceuticals was founded by Donn M. Dennis, Nikolaus Gravenstein, Jerome H. Modell and Timothy E. Morey in 2002 and is headquartered in Middleton, WI. | Director/Board Member | 25/11/2009 | - |
Founder | 01/01/2002 | - |
Training of Timothy E. Morey
University of Florida | Doctorate Degree |
Statistics
International
United States | 3 |
Operational
Director/Board Member | 1 |
Founder | 1 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
NanoMedex Pharmaceuticals, Inc.
![]() NanoMedex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NanoMedex Pharmaceuticals, Inc. develops formulation strategy to allow drugs that are only soluble in oil to be soluble in water. It offers offers Microfol, a micro emulsion formulation containing the generic active pharmaceutical ingredient propofol and two IIG listed excipients-sodium caprylate and poloxamer, which replaces the macro emulsion components of the reference listed drug and its generic equivalents. The company’s formulation is applied to drug classes, including chemotherapeutics, anesthetics, anti-infective, anti-inflammatories and arrythmics, immunosuppressants, and vitamins. NanoMedex Pharmaceuticals was founded by Donn M. Dennis, Nikolaus Gravenstein, Jerome H. Modell and Timothy E. Morey in 2002 and is headquartered in Middleton, WI. | Health Technology |
- Stock Market
- Insiders
- Timothy E. Morey
- Experience